Toggle navigation
The Master Class
UPCOMING EVENTS
IBD Dialogue
Classic Edition
Special Edition
E-Mentoring in IBD
VIDEO
Volume 2 - Issue 1
What does “treat to target” mean to the clinician in 2016?
VIDEO
Volume 2 - Issue 2
What can we learn from the REACT study results?
VIDEO
Volume 2 - Issue 3
What is the role of fecal calprotectin in monitoring in the treat-to-target strategy in IBD?
VIDEO
Volume 2 - Issue 4
What are the benefits and risks of the treat-to-target strategy in IBD?
VIDEO
Volume 2 - Issue 5
What did STRIDE recommend about treat to target in IBD?
VIDEO
Volume 2 - Issue 6
How should patients be monitored for loss of response in the treat-to-target strategy?
VIDEO
Volume 2 - Issue 7
What is the role of transabdominal ultrasound in management of patients with IBD?
VIDEO
Volume 2 - Issue 8
How useful is video capsule endoscopy in diagnosing and monitoring Crohn’s disease?
VIDEO
Volume 2 - Issue 9
What is the relation between extraintestinal manifestations and treatment choice in IBD?
VIDEO
Volume 2 - Issue 10
How is shared decision-making evolving in IBD practice?
VIDEO
Volume 2 - Issue 11
What does treat to target really mean in IBD?
VIDEO
Volume 2 - Issue 12
What is the importance of the treat-to-target strategy in pediatric patients with IBD?
MIIBD Publications
E-Mentoring in IBD
Volume 08 • 2015
Volume 09 • 2016
Volume 10 • 2017
Volume 11 • 2018
Volume 12 • 2019
Volume 13 • 2020
Volume 14 • 2021
Volume 15 • 2022
Volume 16 • 2023
IBD Dialogue
Classic Edition
Volume 11 • 2015
Volume 12 • 2016
Volume 13 • 2017
Volume 14 • 2018
Volume 15 • 2019
Volume 16 • 2020
Volume 17 • 2021
Volume 18 • 2022
Volume 19 • 2023
Special Edition
Therapeutic Drug Monitoring in Clinical Practice
Treat To Target in IBD